Balance Sheet: Q32 Bio’s equity has deteriorated from $72.99M in 2023 to -$4.01M in Q1 2025, with total liabilities surging to $83.08M. Despite a strong current ratio (4.7), negative equity and rising long-term debt (debt-to-equity 1.68) signal solvency risks.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
View 5 tickers daily
Create and manage Watchlists
Import portfolios (no personalized insights)
Chat with the general Sagehood AI Agent
Market Radar: Preview access only
Premium Membership
Unlimited AI-generated insights across all sections
Market Overview
Market Radar (AI-driven investment opportunities)
Access to all Sagehood AI agents, including domain-specific experts
Personalized insights and actionable recommendations for smarter investing